Interferon beta-like molecules for treatment of stroke

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/21 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2477577

The present invention relates to use of interferon beta-like polypeptides for treatment of stroke or transient ischemic attach in a primate, preferably in a human. More particularly, the interferon beta-like polypeptides differs from the amino acid sequence of wild-type human IFNB (SEQ ID NO:2) in that at least one glycosylation site, preferably at least one in vivo N-glycosyltaion site has been introduced. Optionally the interferon beta-like polypeptides are PEGylated.

L'invention concerne l'utilisation de polypeptides de type interféron-bêta pour le traitement d'accidents vasculaires cérébraux ou d'accidents ischémiques transitoires chez les primates, de préférence chez l'être humain. Plus particulièrement, lesdits polypeptides de type interféron-bêta diffèrent de la séquence d'acide aminés d'IFNB (SEQ ID NO:2) humain de type sauvage en ce que au moins un site de glycosylation, de préférence au moins un site de N-glycosylation in vivo a été introduit. Eventuellement, lesdits polypeptides de type interféron-bêta sont pégylés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Interferon beta-like molecules for treatment of stroke does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interferon beta-like molecules for treatment of stroke, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interferon beta-like molecules for treatment of stroke will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1884179

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.